UBS’s Veradigm Inc. Common Stock MDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$20K Buy
1,500
+1,000
+200% +$15.2K ﹤0.01% 8030
2014
Q2
$8K Sell
500
-600
-55% -$9.36K ﹤0.01% 9124
2014
Q1
$20K Sell
1,100
-9,500
-90% -$164K ﹤0.01% 8090
2013
Q4
$164K Buy
10,600
+3,200
+43% +$47.2K ﹤0.01% 5511
2013
Q3
$110K Sell
7,400
-9,600
-56% -$145K ﹤0.01% 5907
2013
Q2
$220K Buy
+17,000
New +$228K ﹤0.01% 4993

Other funds holding MDRX

UBS's MDRX Position: Q3 2014 in Review

UBS increased its Veradigm Inc. Common Stock (MDRX) stake by 31% in Q3 2014, buying an estimated $4.75M and bringing the position to 1,311,935 shares worth $17.6M. The position accounts for 0.01% of the portfolio, ranked #1041.

UBS first reported a position in MDRX in Q2 2013 and has held it in 6 quarters since. 225 funds tracked by Wall St. Rank hold MDRX as of Q3 2014.

  • UBS held 1,311,935 shares of Veradigm Inc. Common Stock worth $17.6M as of Q3 2014.
  • UBS bought 313,606 Veradigm Inc. Common Stock shares in Q3 2014, an estimated $4.75M.
  • Veradigm Inc. Common Stock made up 0.01% of UBS's portfolio in Q3 2014, its #1041 holding.
  • UBS first reported a position in Veradigm Inc. Common Stock in Q2 2013 and has held it in 6 quarters since.
  • 225 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.